Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04360538 · ClinicalTrials.gov registry record

Long Term Outcomes of Patients With COVID-19

A clinical trial of COVID-19 and Critical Illness, sponsored by University of Chicago.

Active
Registry status
500
Enrollment target
1
Study location

NCT04360538 is a study of COVID-19 and Critical Illness that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 500 participants, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04360538, a study of COVID-19 and Critical Illness, is active but no longer recruiting, sponsored by University of Chicago.

ACTIVE NOT RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

The investigators hypothesize that those with respiratory failure due to COVID-19 will have different burdens of mental and physical disability than those with respiratory failure who do not have COVID-19. Detecting these potential differences will lay an important foundation for treating long term sequelae of respiratory failure in these two cohorts.

Interventions

  • OTHER Quality of Life
  • OTHER Impact Event Score
  • OTHER Hospital anxiety and depression scale

Study Locations (1)

Illinois

  • University of Chicago Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2020-04-08
Est. Completion 2026-06-01

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT04360538

The ClinicalTrials.gov registry entry for NCT04360538 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with COVID-19 appearing as the primary indexed condition, and to 3 interventions - of which Quality of Life is the first listed.

NCT04360538 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04360538 about?

NCT04360538 is a clinical study titled "Long Term Outcomes of Patients With COVID-19". The investigators hypothesize that those with respiratory failure due to COVID-19 will have different burdens of mental and physical disability than those with respiratory failure who do not have COVID-19. Detecting these potential differences will lay an important foundation for treating long term ...

What is the current status of trial NCT04360538?

This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2020-04-08. Estimated completion is 2026-06-01.

What conditions does trial NCT04360538 study?

This clinical trial studies the following conditions: COVID-19, Critical Illness, Respiratory Failure, Corona Virus Infection.

What interventions are being tested in trial NCT04360538?

The interventions under investigation include: Quality of Life (OTHER), Impact Event Score (OTHER), Hospital anxiety and depression scale (OTHER).

Who is sponsoring clinical trial NCT04360538?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04360538 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.